Overdiagnosis and overtreatment of breast cancer -: Rates of ductal carcinoma in situ:: a US perspective

被引：22

作者：

Kumar, AS ^{[1
]}

Bhatia, V ^{[1
]}

Henderson, IC ^{[1
]}

机构：

[1] Univ Calif San Francisco, San Francisco, CA 94115 USA

来源：

BREAST CANCER RESEARCH | 2005年 / 7卷 / 06期

关键词：

D O I：

10.1186/bcr1346

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The incidence of breast ductal carcinoma in situ ( DCIS) in the USA exceeds that of other countries. This cannot be explained entirely by the frequency of mammographic screening in the USA and may result from differences in the interpretation of mammograms and/or the frequency with which biopsies are obtained. Although the percentage of DCIS patients treated with mastectomy has decreased, the absolute number is unchanged and the use of lumpectomy with whole-breast radiotherapy has increased in inverse proportion to the decrease in mastectomy. Treatment of DCIS with tamoxifen is still limited.

引用

页码：271 / 275

页数：5

共 21 条

[1] Trends in the treatment of ductal carcinoma in situ of the breast [J].

Baxter, NN ;

Virnig, BA ;

Durham, SB ;

Tuttle, TM .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (06) :443-448

[2] Screening for breast cancer: Recommendations and rationale [J].

Berg, AO ;

Allan, JD ;

Frame, PS ;

Homer, CJ ;

Johnson, MS ;

Klein, JD ;

Lieu, TA ;

Mulrow, CD ;

Orleans, CT ;

Peipert, JF ;

Pender, NJ ;

Siu, AL ;

Teutsch, SM ;

Westhoff, C ;

Woolf, SH .

ANNALS OF INTERNAL MEDICINE, 2002, 137 (05) :344-346

[3] The management of ductal carcinoma in situ in north America and Europe - Results of a survey [J].

Ceilley, E ;

Jagsi, R ;

Goldberg, S ;

Kachnic, L ;

Powell, S ;

Taghian, A .

CANCER, 2004, 101 (09) :1958-1967

[4]

COOPER N, 2005, CANC TRENDS ENGLAND

[5] International variation in screening mammography interpretations in community-based programs [J].

Elmore, JG ;

Nakano, CY ;

Koepsell, TD ;

Desnick, LM ;

D'Orsi, CJ ;

Ransohoff, DF .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (18) :1384-1393

[6] Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program [J].

Ernster, VL ;

Barclay, J ;

Kerlikowske, K ;

Wilkie, H ;

Ballard-Barbash, R .

ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (07) :953-958

[7]

Ernster VL, 2002, JNCI-J NATL CANCER I, V94, P1546

[8] Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial [J].

Fisher, B ;

Dignam, J ;

Wolmark, N ;

Wickerham, DL ;

Fisher, ER ;

Mamounas, E ;

Smith, R ;

Begovic, M ;

Dimitrov, NV ;

Margolese, RG ;

Kardinal, CG ;

Kavanah, MT ;

Fehrenbacher, L ;

Oishi, RH .

LANCET, 1999, 353 (9169) :1993-2000

[9] LUMPECTOMY COMPARED WITH LUMPECTOMY AND RADIATION-THERAPY FOR THE TREATMENT OF INTRADUCTAL BREAST-CANCER [J].

FISHER, B ;

COSTANTINO, J ;

REDMOND, C ;

FISHER, E ;

MARGOLESE, R ;

DIMITROV, N ;

WOLMARK, N ;

WICKERHAM, DL ;

DEUTSCH, M ;

ORE, L ;

MAMOUNAS, E ;

POLLER, W ;

KAVANAH, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (22) :1581-1586

[10]

Fisher ER, 1999, CANCER-AM CANCER SOC, V86, P429, DOI 10.1002/(SICI)1097-0142(19990801)86:3<429::AID-CNCR11>3.0.CO

← 1 2 3 →